Moderna Inc (MRNA)

$ 26.22
   
  • Change Today:
    $-0.67
  • 52 Week High: $89.96
  • 52 Week Low: $23.65
  • Currency: US Dollars
  • Shares Issued: 386.00m
  • Volume: 5,643,695
  • Market Cap: $10,121m
  • RiskGrade: 392
  • Beta: 0.06

Moderna shares surge on cancer trial combo with Merck treatment

By Frank Prenesti

Date: Thursday 14 Dec 2023

LONDON (ShareCast) - (Sharecast News) - Shares in Moderna surged on Thursday after trial results of its experimental cancer vaccine, used in conjunction with Merck's Keytruda treatment, reduced the risk of death or relapse in patients with the most deadly form of skin cancer after three years.


The duo said the combination of drugs slashed the risk of death or recurrence by 49% in patients in later stages of the disease compared to those who received Keytruda only after three years. It also reduced the risk of melanoma spreading to other parts of the body by 62%.

"These data add another positive analysis to the multiple endpoints and subgroups previously assessed in this study," said Dr. Kyle Holen, head of development, therapeutics and oncology at Moderna.

Reporting by Frank Prenesti for Sharecast.com

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Moderna Inc Market Data

Currency US Dollars
Share Price $ 26.22
Change Today $ -0.67
% Change -2.49 %
52 Week High $89.96
52 Week Low $23.65
Volume 5,643,695
Shares Issued 386.00m
Market Cap $10,121m
Beta 0.06
RiskGrade 392

Trades for 21-Aug-2025

Time Volume / Share Price
16:00 573,313 @ $26.22
15:59 200 @ $26.23
15:59 1,583 @ $26.23
15:59 100 @ $26.23
15:59 400 @ $26.23

Top of Page